TY  - JOUR 
AU  - Cañueto Álvarez, Javier
AU  - Muñoz-Couselo, E
AU  - Cardona-Machado, C
AU  - Becerril-Andrés, Sara
AU  - Martín Vallejo, Francisco Javier
AU  - Serra-Guillén, C
AU  - Soria, A
AU  - Serrano-Domingo, J J
AU  - Ortiz-Velez, C
AU  - Lostes, J
AU  - García-Castaño, A
AU  - Puig, S
AU  - Fernández de Misa, R
AU  - Medina, J
AU  - Aguado, C
AU  - Ayala de Miguel, P
AU  - Navarro-Navarro, I
AU  - Masferrer, E
AU  - Delgado, M
AU  - Bellido-Hernández, L
AU  - Sanmartin, O
PY  - 2024
SN  - 0926-9959
UR  - http://hdl.handle.net/10366/168278
AB  - [EN]In this retrospective, observational, multicentre study,we searched for patients who were treated with systemic cemiplimab for advanced CSCC from 12 different Spanish centres (from 2019 to 2022). Patient demographics, primary tumour clinical and...
LA  - eng
PB  - Wiley
KW  - Cemiplimab
KW  - Cutaneous squamous cell carcinoma
KW  - Multicentre real-world retrospective study
KW  - Aged
KW  - Skin Neoplasms
KW  - Carcinoma
KW  - Antibodies
KW  - Treatment Outcome
KW  - Humans
KW  - Antineoplastic Agents
KW  - Middle Aged
KW  - Retrospective Studies
TI  - Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real-world retrospective study from Spain and systematic review of the published data.
DO  - 10.1111/jdv.19821
T2  - Journal of the European Academy of Dermatology and Venereology : JEADV
VL  - 38
M2  - e666
ER  -